A drug device combination product is composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product. Under 21 CFR 3.2 (e), a combination product is defined as a product comprised of two or more regulated components (i.e., drug/device, biologic/device, drug/biologic, or drug/device/biologic) that are physically, chemically, or otherwise combined or mixed and produced as a single entity; and, two or more separate products packaged together in a single package or as a unit and comprised of drug and device products, device and biological products, or biological and drug products.
According to a market research report Drug Device Combination Products Market 2016-2020 published by iHealthcareAnalyst, Inc., the global drug device combination products market is estimated to reach USD 120 Billion in 2020, expanding at a CAGR of 6.6% from 2016 to 2020.
Visit the Drug Device Combination Products Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/drug-device-combination-products-market/
The global drug device combination products market segmentation is based on device types (drug eluting stents, coronary stents, peripheral vascular stents, infusion pumps, implantable infusion pumps, ambulatory infusion pumps, photosensitizers, orthopedic combination products, antibiotic bone cement, bone graft implants, wound care combination products, antibiotic wound care products, inhalers, nebulizers, metered dose inhalers, dry powder inhalers, transdermal patches, intraocular implants, drug eluting beads).
The global drug device combination products market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global drug device combination products market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Device Type
1.1 Drug Eluting Stents
1.1.1 Coronary stents
1.1.2 Peripheral Vascular Stents
1.2 Infusion Pumps
1.2.1 Implantable Infusion Pumps
1.2.2 Ambulatory Infusion Pump
1.4 Orthopedic Combination Products
1.4.1 Antibiotic Bone Cement
1.4.2 Bone Graft Implants
1.5 Wound Care Combination Products
1.5.1 Antibiotic Wound Care Products
1.6.2 Metered Dose Inhalers
1.6.3 Dry Powder Inhalers
1.7 Transdermal Patches
1.8 Others (Intraocular Implants, Drug Eluting Beads, etc.)
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 Abbott Laboratories
3.2 Allergan, Inc.
3.3 Alcon, Inc.
3.4 Arrow International, Inc.
3.5 Bausch & Lomb, Inc.
3.6 Boston Scientific Corporation
3.7 CareFusion Corporation
3.8 Covidien PLC
3.9 C.R. Bard, Inc.
3.10 Ethicon, Inc.
3.11 Medline Industries, Inc.
3.13 Medtronic, Inc.
3.14 Mylan, Inc.
3.15 Pinnacle Biologics, Inc.
3.16 Stryker Corporation
3.17 Terumo Corporation
3.18 W.L. Gore & Associates, Inc.
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.